National Institute of Allergy and Infectious Diseases, National Institutes of Health
GHTC endorses letter urging robust funding for NIH in FY20 appropriations bill

GHTC endorsed a letter from the Ad Hoc Group for Medical Research urging House and Senate appropriators to work quickly to adopt a meaningful increase to the fiscal year 2020 (FY20) Labor, Health and Human Services, Education, and Related Agencies appropriations bill and provide a robust funding increase for the National Institutes of Health.


PATH/Ruhani Kaur
GHTC endorses letter calling for robust TB funding in FY20 appropriations bill

GHTC endorsed a letter from the TB Roundtable to House and Senate appropriators urging the adoption of robust funding levels for tuberculosis (TB) programs at the US Agency for International Development and Centers for Disease Control and Prevention in final fiscal year 2020 (FY20) appropriations bills. The letter also urges appropriators to restore TB as a disease eligible for funding under the Department of Defense’s Peer Reviewed Medical Research Program.


Flickr/Kent MacElwee
GHTC endorses STOP Neglected Diseases of Poverty Act

GHTC endorsed the STOP (Study, Treat, Observe, and Prevent) Neglected Diseases of Poverty Act, a piece of legislation introduced by Senator Cory Booker (D-NJ) aimed at advancing the tools necessary to address and ultimately eliminate neglected disease of poverty in the United States.

Learn More

PATH/Matthew Dakin
GHTC sends FY21 letter to OMB

GHTC sent a letter to the White House Office of Management and Budget (OMB), calling for the administration to sustain and protect global health R&D in the fiscal year 2021 (FY21) budget.


All News


Breakthroughs Blog

GHTC in the Media

Advocacy Actions

Our members work to improve health worldwide